Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
![](../../images/overlap_matrix_icon.png)
9
Number of overlapping holdings
13.4%
% of PSCH's 67 holdings also in SBIO
10.0%
% of SBIO's 90 holdings also in PSCH
Overlap by Weight
Sector Drift (PSCH minus SBIO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PSCH |
Weight in SBIO |
Overlap | |
---|---|---|---|---|
KRYSTAL BIOTECH, INC. | 3.5% | 3.8% | 3.5% | |
ALKERMES PLC | 3.4% | 3.3% | 3.3% | |
CORCEPT THERAPEUTICS INC | 2.3% | 2.5% | 2.3% | |
PROTAGONIST THERAPEUTICS, INC. | 1.8% | 1.7% | 1.7% | |
VERICEL CORPORATION | 1.8% | 1.7% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
PSCH Overweight Relative to SBIO
ENSIGN GROUP INC/THE | 6.1% | |
GLAUKOS CORP | 4.8% | |
ORGANON & CO. | 4.1% | |
MERIT MEDICAL SYSTEMS INC | 4.0% | |
RADNET INC | 3.1% | |
INTEGER HOLDINGS CORPORATION | 3.1% | |
SELECT MEDICAL HOLDINGS CORP | 2.7% | |
PRESTIGE BRANDS HOLDINGS INC | 2.7% | |
ICU MEDICAL INC | 2.4% | |
CORVEL CORP | 2.1% |
PSCH Underweight Relative to SBIO
AVIDITY BIOSCIENCES INC | -2.9% | |
CRINETICS PHARMACEUTICALS INC | -2.9% | |
ARCELLX, INC. | -2.5% | |
DENALI THERAPEUTICS INC. | -2.4% | |
AMICUS THERAPEUTICS INC | -2.4% | |
MERUS N.V. | -2.3% | |
IDEAYA BIOSCIENCES, INC. | -2.1% | |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -2.0% | |
GERON CORP | -1.9% | |
ACADIA PHARMACEUTICALS INC | -1.9% |